OMADA HEALTH INC SEC Filings

Insider transaction summary: A Form 4 shows that Trevor Fetter, a director of Omada Health, Inc. (OMDA), was granted 712 restricted stock units (RSUs) on 10/05/2025 as payment under the non-employee director compensation program in lieu of retainer fees. Each RSU converts to one share at settlement and the grant carried a reported price of $0 (i.e., issued as compensation). After the grant, the filing reports Mr. Fetter directly beneficially owns 10,705 shares and indirectly beneficially owns 111,200 shares through an LLC he solely controls, for a combined beneficial position of 121,905 shares.

The form was signed by an attorney-in-fact on 10/07/2025. The filing discloses that settlement timing follows plan terms and that the indirect holdings are held via the limited liability company of which Mr. Fetter is the sole member.

Insider transaction by Omada Health director Jeryl L. Hilleman: the filing reports that on 10/05/2025 the reporting person was granted 1,126 restricted stock units (RSUs) under the company’s Non-Employee Director Compensation Program in lieu of cash retainer fees. Each RSU represents the right to receive one share of common stock with settlement terms set by the Program. After the grant, the reporting person beneficially owns 11,238 shares of common stock. The RSUs were recorded at a price of $0 because they were compensation awards rather than purchases. The Form 4 was signed by an attorney-in-fact on 10/07/2025.

Steven L. Cook, Chief Financial Officer of Omada Health, Inc. (OMDA), reported a sale of shares on 09/05/2025. The Form 4 shows a disposition of 2,006 shares of common stock at a price of $24.28 per share, leaving Mr. Cook with 63,783 shares owned directly after the transaction. The filing was signed by an attorney-in-fact on 09/09/2025.

Sean P. Duffy, Omada Health insider sale disclosed. The filing shows that on 09/05/2025 Mr. Duffy, who serves as Chief Executive Officer and a Director, disposed of 4,413 shares of Omada Health common stock at a price of $24.28 per share. After the sale his reported direct beneficial ownership is 140,323 shares. The filing also reports 861,109 shares held indirectly in family trusts for the benefit of his family, which he disclaims beneficial ownership of except to the extent of any pecuniary interest. The Form 4 was signed by an attorney-in-fact on 09/09/2025.

Omada Health insider sale: The Form 4 shows Wei-Li Shao, President and officer of Omada Health, sold 2,407 shares of common stock on 09/05/2025 at a price of $24.28 per share. After the sale, Shao beneficially owned 76,540 shares, reported as direct ownership. The filing was signed by an attorney-in-fact on 09/09/2025.

Omada Health, Inc. Schedule 13G shows that a set of related reporting persons (U.S. Venture Partners X, L.P.; USVP X Affiliates, L.P.; Presidio Management Group X, L.L.C.; and Casey M. Tansey) report collective beneficial ownership of the company's common stock. The filings report 4,571,769 shares held directly by USVP X and an additional 146,257 shares held by USVP X Affiliates, for a combined reported position of 4,718,026 shares. The filing states this represents approximately 8.2% of the outstanding common stock based on 57,574,921 shares of common stock outstanding used for the calculation. The reporting persons disclaim group status and clarify that Presidio Management Group X, L.L.C. acts as general partner and certain named individuals may be deemed to share voting and dispositive power, while each disclaims beneficial ownership except to the extent of any pecuniary interest.

The filing is a Schedule 13G disclosing that Andreessen Horowitz-related entities and principals report beneficial ownership in Omada Health, Inc. (OMDA) as of June 30, 2025. Andreessen Horowitz Fund IV, L.P. directly holds 4,210,602 shares (reported as 7.6% of the class) and AH Parallel Fund IV, L.P. directly holds 403,972 shares (reported as 0.7% of the class), producing an aggregate reported position of 4,614,574 shares, equal to 8.3% of outstanding common stock based on 55,744,340 shares outstanding per the issuer prospectus dated June 5, 2025. The filing identifies Andreessen and Horowitz as individuals with shared voting and dispositive power over the aggregated holdings and includes powers of attorney and a joint filing agreement.

Revelation-affiliated entities and two managing members reported beneficial ownership positions in Omada Health's common stock. Michael Boggs and Scott Halsted each report beneficial ownership of 5,208,034 shares, representing 9.1% of the outstanding stock, while Revelation Healthcare Fund IV reports 3,095,306 shares (5.4%). Several Revelation entities report smaller positions (0.9%–2.3%).

The statement shows these reporting persons have sole voting and sole dispositive power over the shares disclosed and uses a public share count of 56,929,340 shares to calculate percentages. The filing is a disclosure of ownership levels by related funds and their managers; it does not announce transactions, changes in control, or other operational developments within the company.

Omada Health reported accelerating commercial growth with materially stronger liquidity following its IPO. Revenue rose to $61.4 million for the quarter and $116.3 million for the six months, increases of 49% and 52% year-over-year, driven by services and connected-device sales. Gross profit expanded while operating loss narrowed to $4.3 million for the quarter and $12.7 million for six months, reflecting higher revenue and continued investment in R&D, sales and marketing, and G&A.

The company closed an IPO that generated $151.6 million of net proceeds and converted all redeemable convertible preferred stock into common shares, leaving cash and cash equivalents of $223.1 million and eliminating prior preferred-stock balances and related warrant liabilities. Omada reported over 752,000 enrolled members and maintains a $30.0 million term facility (repaid subsequent to period). Despite improved liquidity and revenue momentum, the company remains loss-making with a substantial accumulated deficit.